154 related articles for article (PubMed ID: 8558914)
21. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of human CD34+ cells that express low or high levels of the membrane antigen CD111 (nectin 1).
Belaaloui G; Imbert AM; Bardin F; Tonnelle C; Dubreuil P; Lopez M; Chabannon C
Leukemia; 2003 Jun; 17(6):1137-45. PubMed ID: 12764381
[TBL] [Abstract][Full Text] [Related]
23. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.
Sawada K; Krantz SB; Dai CH; Koury ST; Horn ST; Glick AD; Civin CI
J Cell Physiol; 1990 Feb; 142(2):219-30. PubMed ID: 2154501
[TBL] [Abstract][Full Text] [Related]
24. A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T cells.
Bernard A; Gay-Bellile V; Amiot M; Caillou B; Charbord P; Boumsell L
J Immunol; 1984 May; 132(5):2338-44. PubMed ID: 6425401
[TBL] [Abstract][Full Text] [Related]
25. In vitro apoptotic cell death during erythroid differentiation.
Zamai L; Burattini S; Luchetti F; Canonico B; Ferri P; Melloni E; Gonelli A; Guidotti L; Papa S; Falcieri E
Apoptosis; 2004 Mar; 9(2):235-46. PubMed ID: 15004520
[TBL] [Abstract][Full Text] [Related]
26. Onset of expression of the components of the Kell blood group complex.
Pu JJ; Redman CM; Visser JW; Lee S
Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
[TBL] [Abstract][Full Text] [Related]
27. Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages.
Kobayashi M; Imamura M; Uede T; Sakurada K; Maeda S; Iwasaki H; Tsuda Y; Musashi M; Miyazaki T
Stem Cells; 1994 May; 12(3):316-21. PubMed ID: 7521241
[TBL] [Abstract][Full Text] [Related]
28. ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens.
Rollins-Raval MA; Fuhrer K; Marafioti T; Roth CG
Am J Clin Pathol; 2012 Jan; 137(1):30-8. PubMed ID: 22180476
[TBL] [Abstract][Full Text] [Related]
29. Ontogeny of hematopoietic stem cell development: reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitors.
Brashem-Stein C; Flowers DA; Smith FO; Staats SJ; Andrews RG; Bernstein ID
Blood; 1993 Aug; 82(3):792-9. PubMed ID: 8338945
[TBL] [Abstract][Full Text] [Related]
30. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
Hestdal K; Ruscetti FW; Ihle JN; Jacobsen SE; Dubois CM; Kopp WC; Longo DL; Keller JR
J Immunol; 1991 Jul; 147(1):22-8. PubMed ID: 1711076
[TBL] [Abstract][Full Text] [Related]
31. [Terminal differentiation of human peripheral blood CD34 positive cells to reticulocytes in vitro and effects of cytoskeletal modifiers on enucleation].
Fukada Y
Hokkaido Igaku Zasshi; 1998 Nov; 73(6):543-56. PubMed ID: 10036613
[TBL] [Abstract][Full Text] [Related]
32. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
33. Anti-K562 cell monoclonal antibody RTF8X recognizes tumor-associated antigen of erythroid lineage.
Sakurai T; Hara H; Nagai K
Blood; 1988 Nov; 72(5):1487-91. PubMed ID: 3052624
[TBL] [Abstract][Full Text] [Related]
34. Identification of cell surface antigens present on murine hematopoietic stem cells.
Miller BA; Antognetti G; Springer TA
J Immunol; 1985 May; 134(5):3286-90. PubMed ID: 3980993
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
[TBL] [Abstract][Full Text] [Related]
36. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
[TBL] [Abstract][Full Text] [Related]
37. Clonogenicity, gene expression and phenotype during neutrophil versus erythroid differentiation of cytokine-stimulated CD34+ human marrow cells in vitro.
Edvardsson L; Dykes J; Olsson ML; Olofsson T
Br J Haematol; 2004 Nov; 127(4):451-63. PubMed ID: 15521924
[TBL] [Abstract][Full Text] [Related]
38. Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells.
Uoshima N; Ozawa M; Kimura S; Tanaka K; Wada K; Kobayashi Y; Kondo M
Br J Haematol; 1995 Sep; 91(1):30-6. PubMed ID: 7577648
[TBL] [Abstract][Full Text] [Related]
39. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
40. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]